Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Gui

Showing results (291-300 of 298) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 298 results.
Clinical and Molecular Hepatology|March 4, 2025
CD36 Promotes Iron Accumulation and Dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular CarcinomaYifei Qin, Fei Huo, Zhuan Feng, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Eclinicalmedicine|May 30, 2023
Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort studyJianwei Liao, Yu Gui, Zhilin Li, et al.
Nature Methods|August 18, 2025
High-throughput profiling of chemical-induced gene expression across 93,644 perturbationsLei Xiang, Yumei Wang, Wei Shao, et al.
Journal of Medicinal Chemistry|June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitorsClarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Journal of Medicinal Chemistry|February 15, 2007
N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy derivatives as acetyl-coA carboxylase inhibitors--improvement of cardiovascular and neurological liabilities via structural modificationsYu Gui Gu, Moshe Weitzberg, Richard F Clark, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
Pageof 30

Showing results (291-300 of 298) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 298 results.
Clinical and Molecular Hepatology|March 4, 2025
CD36 Promotes Iron Accumulation and Dysfunction in CD8+ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular CarcinomaYifei Qin, Fei Huo, Zhuan Feng, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variantsRichard F Clark, Sanyi Wang, Zhenkun Ma, et al.
Eclinicalmedicine|May 30, 2023
Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort studyJianwei Liao, Yu Gui, Zhilin Li, et al.
Nature Methods|August 18, 2025
High-throughput profiling of chemical-induced gene expression across 93,644 perturbationsLei Xiang, Yumei Wang, Wei Shao, et al.
Journal of Medicinal Chemistry|June 10, 2005
Structure-based characterization and optimization of novel hydrophobic binding interactions in a series of pyrrolidine influenza neuraminidase inhibitorsClarence J Maring, Vincent S Stoll, Chen Zhao, et al.
Journal of Medicinal Chemistry|February 15, 2007
N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy derivatives as acetyl-coA carboxylase inhibitors--improvement of cardiovascular and neurological liabilities via structural modificationsYu Gui Gu, Moshe Weitzberg, Richard F Clark, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
Pageof 30